Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2025)

Historic Inventory for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $45.3 million.

  • Maravai Lifesciences Holdings' Inventory fell 1030.59% to $45.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.3 million, marking a year-over-year decrease of 1030.59%. This contributed to the annual value of $50.1 million for FY2024, which is 255.85% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Inventory stood at $45.3 million for Q3 2025, which was down 1030.59% from $46.7 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Inventory registered a high of $62.4 million during Q3 2022, and its lowest value of $43.2 million during Q4 2022.
  • Its 5-year average for Inventory is $50.7 million, with a median of $49.8 million in 2024.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Inventory soared by 5482.12% in 2021, and later crashed by 2127.71% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Inventory (Quarter) stood at $51.6 million in 2021, then dropped by 16.3% to $43.2 million in 2022, then rose by 19.11% to $51.4 million in 2023, then fell by 2.56% to $50.1 million in 2024, then dropped by 9.5% to $45.3 million in 2025.
  • Its last three reported values are $45.3 million in Q3 2025, $46.7 million for Q2 2025, and $49.8 million during Q1 2025.